HOME > ALL ABOUT US > NEWS ROOM > EXPERTS GUIDE > HARDY

Karen Hardy, MD

Karen Hardy, MD
Oakland Magazine Best East Bay Doctors 2007-2008
(nat'l survey)

Director, Division of Pulmonology Medicine

Director, Cystic Fibrosis Center

Medical Director, Children's Hospital Oakland Sleep Lab, Respiratory Therapy

Director, Bay Area Pediatric Pulmonary Medical Corporation


Medical School: Medical College of Ohio

Residency: Children’s Hospital & Research Center Oakland

Fellowship: Pedicatric Pulmonology, St. Christopher's Hospital for Children, Philadelphia

Board Certification: Pediatrics, Pediatric Pulmonology

Language(s): English, German

 

News Room: Experts Guide

Karen Hardy, MD, Pulmonology Medicine

Summary

Karen Hardy, MD, has expertise in the area of pediatric pulmonology, and clinical research and trials for asthma and cystic fibrosis patients. For her expertise, she was named one of the Bay Area’s “Best Doctors” in 2004 and 2005 by San Francisco magazine. Dr. Hardy is a nationally renowned physician, repeatedly invited to lecture on respiratory topics. She is comfortable discussing topics related to pediatric pulmonology, such as asthma, cystic fibrosis, tracheotomies, bronchiolititis, and any and all congenital airway abnormalities found in infants and young children.

Compelling Fact

Asthma is the most common chronic childhood disorder, affecting about 6.5 million children under 18 in the United States. Asthma is the third leading cause of hospitalization among children under 15. In 2004, 641,242 emergency room visits were due to asthma in those under 15. It is the leading cause of school absenteeism.

Source: American Lung Association
http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=44352


Expertise

  • Asthma
  • Cystic fibrosis
  • Tracheotomy/Home ventilation
  • All congenital airway abnormalities in infants and children

Cystic Fibrosis
Cystic fibrosis is a genetic disorder currently affecting more than 30,000 children and young adults in the United States. About 1,000 babies with the disease are born each year, meaning about 1 of every 25 people in the United States carries the gene and about 1 of every 3,700 babies born has the disease. CF affects the normal movement of salt (sodium chloride) in and out of certain cells. As a result, the lungs of affected children fill with thick secretions that block the breathing passageways and lead to recurrent infections and damage to the lungs. In most patients, secretions retained in the pancreas block the flow of digestive enzymes, causing poor absorption of food and vitamins, which leads to poor nutrition and growth.

Professional and Personal background

You can reach this physician by contacting Media Relations.

Back to top

>Subscribe to e-news

>Become an advocate

>Volunteer

>Make a donation

>Buy a gift for a patient

>Get Directions

>Careers

>News Room

>Publications

  •  + Favorite
  • Email page
  • Print page
  •     Contact us